Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition
- 1 May 2006
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 112 (2) , 208-213
- https://doi.org/10.1016/j.jconrel.2006.02.014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Paclitaxel nanoparticles for the potential treatment of brain tumorsJournal of Controlled Release, 2004
- Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticlesBiomaterials, 1999
- Overexpression of Multidrug Resistance Protein Gene in Human Cancer Cell Lines Selected for Drug Resistance to EpipodophyllotoxinsJapanese Journal of Cancer Research, 1996
- Failure of liposomal encapsulation of doxorubicin to circumvent multidrug resistance in an in vitro model of rat glioblastoma cellsEuropean Journal Of Cancer, 1995
- Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agentsInternational Journal of Cancer, 1995
- Evaluation of Liver Toxicological Effects Induced by Polyalkylcyanoacrylate NanoparticlesToxicology and Applied Pharmacology, 1995
- Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in cultureEuropean Journal Of Cancer, 1994
- P‐glycoprotein expression in the Golgi apparatus of multidrug‐resistant cellsInternational Journal of Cancer, 1994
- Possible involvement of multidrug‐resistance‐associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cellsInternational Journal of Cancer, 1994
- Cross-resistance patterns in ACNU-resistant glioma sublines in cultureJournal of Neurosurgery, 1991